Emily Whitehead Celebrates Two Milestones

Published on in CHOP News

Emily Whitehead made international headlines when her doctors at Children's Hospital of Philadelphia (CHOP) declared her cancer-free. Emily received an experimental treatment at CHOP in April 2012 after her acute lymphoblastic leukemia (ALL), the most common childhood cancer, relapsed for the second time.

Philly.com caught up with Emily and her family during her 12th birthday celebration — five years after the doctors at CHOP saved her life.

Read the interview on Philly.com.

Next Steps
Existing Patients or Family Members
New Patients, Referrals and 2nd Opinions
Young boy cancer patient outside

Referring a Patient

Here’s what you can expect after contacting the Cancer Immunotherapy Program.

Torie CART

Cancer Immunotherapy Studies

The Cancer Immunotherapy Program has several clinical trials available to qualified patients.

You Might Also Like
Emily with Dr. Grupp

A First in Pediatric Cancer

Emily Whitehead was the first pediatric patient treated with an experimental immunotherapy for advanced acute lymphoblastic leukemia.


Emily Whitehead Foundation Benefits CHOP

The $100,000 the foundation raised will go directly to a new clinical trial testing the treatment Emily received on other types of cancer.

Whitehead family, Steve Altschuler, and Dr. Collins

Precision Medicine at the White House

CHOP sent two guests to President Obama’s announcement of the Precision Medicine Initiative: Dr. Altschuler and Emily Whitehead.